Researcher.Life Logo

Current Pharmaceutical Design : Impact Factor & More

eISSN: 1873-4286pISSN: 1381-6128

Aims and Scope of Current Pharmaceutical Design

Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field. Less

Key Metrics

CiteScore
5.8
H-Index
176
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Pharmaceutical Design

Current Pharmaceutical Design Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Weekly
General Details
LanguageEnglish
FrequencyWeekly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Pharmaceutical Design ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Pharmaceutical Design

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.
  • 30 Jun 2026
  • Current pharmaceutical design
Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.
  • 30 Jun 2026
  • Current pharmaceutical design
Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.
  • 30 Jun 2026
  • Current pharmaceutical design
Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.
  • 30 Jun 2026
  • Current pharmaceutical design
Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.
  • 30 Jun 2026
  • Current pharmaceutical design
Combining Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation to Explore the Mechanism of Danggui-Shaoyao-San in treating Rheumatoid arthritis.
  • 23 Jun 2026
  • Current pharmaceutical design
Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.
  • 30 Jun 2026
  • Current pharmaceutical design
Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.
  • 30 Jun 2026
  • Current pharmaceutical design
Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.
  • 30 Jun 2026
  • Current pharmaceutical design
Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.
  • 30 Jun 2026
  • Current pharmaceutical design
Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.
  • 30 Jun 2026
  • Current pharmaceutical design
Combining Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation to Explore the Mechanism of Danggui-Shaoyao-San in treating Rheumatoid arthritis.
  • 23 Jun 2026
  • Current pharmaceutical design

FAQs on Current Pharmaceutical Design